MyoKardia CEO on genetic heart disease treatments, continued product partnerships
Share

MyoKardia CEO on genetic heart disease treatments, continued product partnerships

The full interview with MyoKardia CEO Tassos Gianakakos at J.P. Morgan Health in San Francisco.
06:16
Mon, Jan 8 20183:30 PM EST